There’s a theory now being embraced by President Donald Trump that the Supreme Court’s recent DACA decision makes it harder for a new president to undo the executive action of a predecessor. He cited it in a recent interview, saying that finding gave him the power to issue new health care and immigration plans. And some legal scholars disagree.
State officials had projected that 2 million Californians would join Medi-Cal, the state’s health insurance program for low-income people, by July because of the economic devastation wrought by COVID-19. Yet enrollment has barely budged, and why is unclear.
With millions out of work because of the coronavirus pandemic, fewer payroll taxes are coming in to help keep Medicare’s trust fund intact.
Under the federal COBRA law, people who lose health coverage because of a layoff or a reduction in their hours generally have 60 days to decide whether to pay to maintain that coverage. But under new regulations, the clock won’t start ticking until the government says the coronavirus national emergency is over, and then consumers will have 120 days to act.
Additional guidance issued late last month by the Trump administration added to the confusion. Some consumers may find themselves unexpectedly on the hook for the cost of a test.
KHN’s Midwest correspondent Lauren Weber drills through the vital health care policy stories of the week, so you don’t have to.
This appears to be an overstatement.
The speech by the presumtive Democrat presidential nominee was delivered the same day the Trump administration reaffirmed its support of a lawsuit that would invalidate all of the Affordable Care Act, including the law’s preexisting condition protections.
Americans who had coronavirus symptoms in March and April are getting big hospital bills — because they were not sick enough to get then-scarce COVID tests. Some insurers say they are trying to correct these bills, but patients may have to put up a fight.
The National Cancer Institute plans to launch a multisite study next year involving roughly 5,000 women to assess whether self-sampling at home for the human papillomavirus that causes cervical cancer is comparable to screening in a doctor’s office.
